Featured Article
Boston Scientific, a global medical technology company, had a strongly positive Q1 2024. Revenue rose 14% to $3.9 billion and earnings before interest and taxes rose 22 % to $674 million over the same period last year. A review of Boston Scientific’s 24 April earnings call and associated financial reports provided insight regarding the importance of pricing on performance. Pricing was not mentioned in their earnings call. Margins were briefly mentioned by…
Read MoreIn This Issue
Variances in fortune telling continue to be told. On one hand, Forester reports an 2.3% increase on IT spending during 2002 over…
Read More XML has been lauded as the language that will enable networked computing to become a full reality. It is the extensible mark…
Read More Business-to-Business companies are increasing their focus on repeat and referral business. In this final installment on driving repeat business, we will review…
Read More Business-to-Business companies are increasing their focus on repeat and referral business. While this may represent a sound strategy, talk is cheap but…
Read More